NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a deal to distribute its SelectMDx for Prostate Cancer test in various countries in Central and South America.

Under the terms of the agreement, Uruguay-based biotechnology company SouthGenetics will have the rights to distribute SelectMDx in Argentina, Bolivia, Chile, Columbia, Ecuador, Mexico, Peru, the Dominican Republic, Panama, Paraguay, Uruguay, and Venezuela.

Further terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.